NasdaqCM:CLPTMedical Equipment
ClearPoint Neuro (CLPT) Stock Sinks As Cash Burn Deepens
ClearPoint Neuro dropped 16% to about US$12.88 after its second quarter report, a sharp move for a stock already under pressure over the past month. The headline is not revenue growth, which reached US$10.9 million. The focus is the growing loss profile and what that means for a company with a short cash runway.
ClearPoint Neuro is leaning hard into an investment year, with higher operating expenses and a cash balance of US$29.4 million at the end of June. The market focused on that strain...